Mastodon

Sponge antiseptic with kanamycin (Sponge) Instructions for Use

Marketing Authorization Holder

Pechery Firm, LLC (Russia)

ATC Code

B02BC30 (Local hemostatics in combinations)

Active Substances

Nitrofural (Rec.INN registered by WHO)

Kanamycin (Rec.INN registered by WHO)

Dosage Form

Bottle OTC Icon Sponge antiseptic with kanamycin Sponge: sachet 1, 100, 200, or 300 pcs.

Dosage Form, Packaging, and Composition

Sponge 1 g
Kanamycin monosulfate 37500 IU
Nitrofural 1.5 mg

Excipients: calcium chloride, gelatin.

1 pc. – laminated paper bags (1) – cardboard packs.
1 pc. – laminated paper bags (100) – cardboard boxes.
1 pc. – laminated paper bags (200) – cardboard boxes.
1 pc. – laminated paper bags (300) – cardboard boxes.

Clinical-Pharmacological Group

Hemostatic agent for topical application

Pharmacotherapeutic Group

Combined antimicrobial agent

Pharmacological Action

Combined antimicrobial agent. It has antibacterial (against gram-positive and gram-negative microorganisms) and hemostatic action, stimulates reparative processes in the wound and accelerates its healing.

Pharmacokinetics

When applied to a wound, the sponge swells within 5-10 seconds and absorbs exudate in an amount 30-40 times its own weight. At the same time, a local depot of kanamycin is created, which, as the sponge dissolves under the action of proteolytic enzymes, enters the wound in a bactericidal concentration. Within 10-14 days, the sponge left in the wound completely dissolves.

Indications

Wounds, including infected wounds and burns of any etiology and location (as a means of individual protection when providing first aid); thermal, chemical and radiation burns of varying severity and location (for biological coverage as part of complex therapy); trophic ulcers; bone defect after sequestrectomy for osteomyelitis; prevention of postoperative complications and development of wound infection; bleeding (including capillary, parenchymal, occurring during surgical interventions and injuries); in dentistry: stopping socket bleeding in hemophilia.

ICD codes

ICD-10 code Indication
L98.4 Chronic skin ulcer, not elsewhere classified
M86 Osteomyelitis
R58 Hemorrhage, not elsewhere classified
T14.1 Open wound of unspecified body region
T30 Burns and corrosions of unspecified body region
T79.3 Posttraumatic wound infection, not elsewhere classified
T88.8 Other specified complications of surgical and medical care, not elsewhere classified
Z29.8 Other specified prophylactic measures
ICD-11 code Indication
EA40 Tropical phagedenic ulcer
EF60 Ischemic ulceration of the skin
EM0Z Unspecified skin disorder
FB84.Z Osteomyelitis or osteitis, unspecified
ME60.2 Ulcerative skin lesion of unspecified nature
MG27 Hemorrhage, not elsewhere classified
ND56.1 Open wound of unspecified body region
NE11 Burn of unspecified body region
NE8Z Injury or harm caused as a result of surgical or therapeutic interventions, not elsewhere classified, unspecified
NF0A.3 Posttraumatic wound infection, not elsewhere classified
QC05.Z Prophylactic measures, unspecified

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Apply topically to the affected area.

Determine the amount of sponge used by the size and area of the wound surface.

Ensure the sponge completely covers the wound, with edges extending slightly onto intact skin.

For heavily exuding wounds, apply multiple layers to ensure adequate absorption.

The total amount of kanamycin with a single use must not exceed 1 million IU.

For extensive wound surfaces, calculate the maximum number of sponges based on this limit.

Leave the sponge in the wound; do not remove it.

The sponge will swell upon application and subsequently dissolve completely within 10-14 days.

Adverse Reactions

Possible: allergic reactions.

Contraindications

Hypersensitivity to the components of the drug, pregnancy, breastfeeding period, childhood.

Use in Pregnancy and Lactation

Use during pregnancy and breastfeeding is contraindicated.

Pediatric Use

Use in children is contraindicated.

Geriatric Use

The drug is approved for use in elderly patients.

Special Precautions

The use of the sponge does not require its subsequent removal (the sponge left in the wound dissolves on its own).

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS